Immune cells in the human choroid

British Journal of Ophthalmology

Volumn 92, Issue 7, 2008, Pages 976-980

  Ezzat, M K ^a   Hann, C R ^a   Vuk Pavlovic, S ^a   Pulido, J S ^a,b  

^a MAYO CLINIC CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CD83 ANTIGEN;

ADULT; AGED; ARTICLE; CHOROID; DRUSEN; EYE BIOPSY; FIBROVASCULAR SCARRING; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOCOMPETENT CELL; LEUKOCYTE; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; SCAR FORMATION;

AGED; AGED, 80 AND OVER; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD14; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHOROID; CICATRIX; HUMANS; IMMUNOPHENOTYPING; MACULAR DEGENERATION; MIDDLE AGED; RETINAL DRUSEN;

EID: 47049127751     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.129742     Document Type: Article

References (26)

1. Kini MM, Leibowitz HM, Colton T,et al. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol 1978;85:28-34.
2. Friedman DS, O'Colmain BJ, Munoz B,et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-72.
3. Klein R, Wang Q, Klein BE,et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 1995;36:182-91.
4. Edwards AO, Flitter R 3rd, Abel KJ,et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-4.
5. Espinosa-Heidmann DG, Suner IJ, Hernandez EP,et al. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003;44:3586-92.
6. Sakurai E, Anand A, Ambati BK, et al. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003;44:3578-85.
7. Shankar A, Mitchell P, Rochtchina E, et al. Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Am J Epidemiol 2007;165:375-82.
8. Anderson DH, Mullins RF, Hageman GS,et al. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002;134:411-31.
9. Apte RS, Richter J, Herndon J,et al. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med 2006;3:e310.
10. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 1985;223:69-76.
11. Penfold P, Killingsworth M, Sarks S. An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. Aust J Ophthalmol 1984;12:23-31.
12. Killingsworth MC, Sarks JP, Sarks SH. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 1990;4:613-21.
13. Gehrs KM, Heriot WJ, de Juan E Jr. Transmission electron microscopic study of a subretinal choroidal neovascular membrane due to age-related macular degeneration. Arch Ophthalmol 1992;110:833-7.
14. Penfold PL, Madigan MC, Gillies MC,et al. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001;20:385-414.
15. Hageman GS, Luthert PJ, Victor Chong NH,et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001;20:705-32.
16. Bird AC. Brassier NM, Brassier SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-74.
17. Dietz AB, Bulur PA, Emery RL. ef a/. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion 2006;46:2083-9.
18. Dietz AB, Bulur PA, Erickson MR,et al. Optimizing preparation of normal dendritic cells and bcr-abl positive mature dendritic cells derived from immunomagnetically purified CD14 positive cells. J Hematotherapy Stem Cell Res 2000;9:95-101.
19. Tchilian EZ, Beverley PC. Altered CD45 expression and disease. Trends Immunol 2006;27:146-53.
20. +dendritic cells. Proc Natl Acad Sci USA 1996;93:2588-92.
21. Hume DA, Ross IL, Himes SR,et al. The mononuclear phagocyte system revisited. J Leukoc Biol 2002;72:621-7.
22. McMenamin PG. The distribution of immune cells in the uveal tract of the normal eye. Eye 1997;11:183-93.
23. Chang JH, McCluskey P, Wakefield D. Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Invest Ophthalmol Vis Sci 2004;45:1871-8.
24. Jiang HR, Lumsden L, Forrester JV. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest Ophthalmol Vis Sci 1999;40:3177-85.
25. + T lymphocyte-rich microenvironments. Arthritis Rheum 2002;46:1210-6.
26. + T cell infiltrations within esophageal carcinomas. Cancer Res 2001;61:3932-6.